|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 368-371, Copyright © 1993 by The Society of Thoracic Surgeons
HM Janzing, A Derom, E Derom, C Eeckhout, F Derom and MT Rosseel
From 1982 to 1990, 27 patients with recurrent pneumothorax or persistent
air leak (28 episodes) underwent pleurodesis with intrapleural
administration of quinacrine, according to a standardized scheme. A first
evaluation was done about 1 month after the intervention. In August 1990,
all patients were invited for a second check-up. In 4 patients quinacrine
plasma concentrations were determined. There was one early failure. No late
recurrences were observed. Neither serious nor late complications were seen
with our low- dose regimen. Transient fever was the only constant side
effect. In contrast to other chemicals proposed for pleurodesis, quinacrine
did not cause major pain. Only very low quinacrine plasma concentrations
(peak, < 10 ng/mL) were found. In conclusion, chemical pleurodesis with
quinacrine can be considered a safe and effective treatment. The number of
administrations as well as the dosage are important to prevent morbidity
and recurrence.
ARTICLES
Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak
Surgical Department, University Hospital, Ghent, Belgium.
This article has been cited by other articles:
![]() |
C. Andreetti, F. Venuta, M. Anile, T. De Giacomo, D. Diso, M. Di Stasio, E. A. Rendina, and G. F. Coloni Pleurodesis with an autologous blood patch to prevent persistent air leaks after lobectomy J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 759 - 762. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |